Resultados de procura - James Doherty
- Mostrando 1 - 20 Resultados de 23
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism por Amit Modgil, Manasa L. Parakala, Michael A. Ackley, James Doherty, Stephen J. Moss, Paul Davies
Publicado 2016Artigo -
6
-
7
-
8
Brexanolone as adjunctive therapy in super‐refractory status epilepticus por Eric S. Rosenthal, Jan Claassen, Mark S. Wainwright, Aatif M. Husain, Henrikas Vaitkevicius, Shane Raines, Ethan Hoffmann, Helen Colquhoun, James Doherty, Stephen Kanes
Publicado 2017Artigo -
9
Dalzanemdor (SAGE‐718), a novel, investigational N‐methyl‐D‐aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose‐fin... por Aaron Koenig, Michael Lewis, Jeff Wald, Sigui Li, Mustafa Varoglu, Jing Dai, Abdul J. Sankoh, Katrina Paumier, James Doherty, Mike Quirk
Publicado 2024Artigo -
10
Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABAA receptors por Manasa L. Parakala, Yihui Zhang, Amit Modgil, Jayashree Chadchankar, Thuy N. Vien, Michael A. Ackley, James Doherty, Paul Davies, Stephen J. Moss
Publicado 2019Artigo -
11
SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies por Ethan Hoffmann, George G. Nomikos, Inder Kaul, Shane Raines, Jeff Wald, Amy Bullock, Abdul J. Sankoh, James Doherty, Stephen Kanes, Helen Colquhoun
Publicado 2019Artigo -
12
-
13
Chemotherapeutic response to cisplatin-like drugs in human breast cancer cells probed by vibrational microspectroscopy por Ana L. M. Batista de Carvalho, Michael J. Pilling, Peter Gardner, James Doherty, Gianfelice Cinque, Katia Wehbe, Chris S. Kelley, Luís A. E. Batista de Carvalho, M. Paula M. Marques
Publicado 2016Artigo -
14
Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis por Natasha Warikoo, Samuel J. Brunwasser, Ann Benz, Hong‐Jin Shu, Steven M. Paul, Michael Lewis, James Doherty, Michael C. Quirk, Laura Piccio, Charles F. Zorumski, Gregory S. Day, Steven Mennerick
Publicado 2018Artigo -
15
Effect of Zuranolone vs Placebo in Postpartum Depression por Kristina M. Deligiannidis, Samantha Meltzer‐Brody, Handan Gunduz‐Bruce, James Doherty, Jeffrey M. Jonas, Sigui Li, Abdul J. Sankoh, Christopher Silber, Andrew Campbell, Brian Werneburg, Stephen Kanes, Robert Lasser
Publicado 2021Artigo -
16
The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator of<i>N</i>-Methyl-d-Aspartate Receptors por Steven M. Paul, James Doherty, Albert J. Robichaud, Gabriel M. Belfort, Brian Y. Chow, Rebecca Hammond, Devon C. Crawford, Andrew J. Linsenbardt, Hong‐Jin Shu, Yukitoshi Izumi, Steven Mennerick, Charles F. Zorumski
Publicado 2013Artigo -
17
Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis por Francesco Mannara, Marija Radosevic, Jesús Planagumà, David Soto, Esther Aguilar, Anna García‐Serra, Estibaliz Maudes, Marta Pedreño, Steven M. Paul, James Doherty, Michael C. Quirk, Jing Dai, Xavier Gasull, Michael Lewis, Josep Dalmau
Publicado 2020Artigo -
18
<scp>AZD</scp>1080, a novel <scp>GSK</scp>3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans por Biljana Georgievska, Johan Sandin, James Doherty, Anette Mörtberg, Jan Neelissen, Anita Andersson, Susanne Gruber, Yvonne Nilsson, P.A. Schött, Per I. Arvidsson, Sven Hellberg, Gunilla Osswald, Stefan von Berg, Johanna Fälting, Ratan V. Bhat
Publicado 2013Artigo -
19
Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study por Sagar V. Parikh, Scott T. Aaronson, Sanjay J. Mathew, Gustavo Alva, Charles DeBattista, Stephen Kanes, Robert Lasser, Amy Bullock, Mona Kotecha, JungAh Jung, Fiona Forrestal, J. Jonas, Theresa Vera, Bridgette Leclair, James Doherty
Publicado 2023Artigo -
20
Trial of SAGE-217 in Patients with Major Depressive Disorder por Handan Gunduz-Bruce, Christopher Silber, Inder Kaul, Anthony J. Rothschild, Robert Riesenberg, Abdul J. Sankoh, Haihong Li, Robert Lasser, Charles F. Zorumski, David R. Rubinow, Steven M. Paul, Jeffrey M. Jonas, James Doherty, Stephen Kanes
Publicado 2019Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Medicine
Internal medicine
Receptor
Neuroscience
Pharmacology
Allosteric regulation
Biochemistry
Chemistry
Allosteric modulator
Pathology
Adverse effect
Alternative medicine
GABAA receptor
Genetics
Glutamate receptor
NMDA receptor
Neuroactive steroid
Physics
Placebo
Cell biology
Hamilton Rating Scale for Depression
Long-term potentiation
Major depressive disorder
Psychiatry
Psychology
Synaptic plasticity
Allopregnanolone
Depression (economics)
Economics